54
Participants
Start Date
August 31, 2012
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
R932333
R393233 6% (60 mg/g), bid
Placebo
Placebo, bid
Columbia University Medical Center, New York
North Shore Long Island Health System, Lake Success
University of Pennsylvania-Dermatology Research Office, Philadelphia
Virginia Clinical Research, Inc, Norfolk
Wake Forest University Health Sciences, Winston-Salem
Memorial Medical Group Clinical Research Institute, South Bend
Oklahoma Medical Research Foundation, Oklahoma City
Metroplex Clinical Research Center, Dallas
University of Texas Medical School at Houston, Houston
University of Utah Department of Dermatology, Salt Lake City
Wallace Rheumatic Study Center, Los Angeles
Stanford Dermatology, Redwood City
University of British Columbia, Vancouver Dermatology Clinical Trials Unit, Vancouver
Dermadvances Research, Winnipeg
Lynderm Research, Inc, Markham
Lead Sponsor
Rigel Pharmaceuticals
INDUSTRY